FDA Inspection
Amgen Manufacturing LtdAmgen Manufacturing Ltd – FDA Inspection, Apr 11, 2019
Record Details
This FDA Inspection record concerns Amgen Manufacturing Ltd, with an inspection on April 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a48ae540-0c6d-47fe-88af-9d124f4994aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085900
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.198(a)Quality Control Review
- 21 CFR 820.30(f)Design verification - output does not meet input requirement
- 21 CFR 606.171Biological product deviation report
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.50Purchasing controls, Lack of or inadequate procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amgen Manufacturing Ltd
19| Date | Classification | Office | Project area |
|---|---|---|---|
| April 27, 2026 | Not classified | San Juan District Office | |
| July 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | San Juan District Office | New Drug Evaluation |
| May 8, 2019 | Not classified | San Juan District Office | |
| August 6, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amgen Manufacturing Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.